← Giovanni Davı̀

Papers by Giovanni Davı̀

Page 1 · newest first

1. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitusJournal of the American College of Cardiology · 2003
2. Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial FibrillationJournal of the American College of Cardiology · 2013
3. The left atrial appendage: from embryology to prevention of thromboembolismEuropean Heart Journal · 2016
4. Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 DiabetesDiabetes Care · 2017
5. Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic ApproachCurrent Medicinal Chemistry · 2017
6. Oxidant stress as a major determinant of platelet activation in invasive breast cancerInternational Journal of Cancer · 2016
7. Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitusThrombosis and Haemostasis · 2016
8. LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitroDiabetologia · 2016
9. Oxidative Stress Modulation Through Habitual Physical ActivityCurrent Pharmaceutical Design · 2016
10. Microparticles as new markers of cardiovascular risk in diabetes and beyondThrombosis and Haemostasis · 2016
11. Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatmentThrombosis and Haemostasis · 2016
12. Pentraxin 3 and Platelet Activation in Obese Patients After Gastric BandingCirculation Journal · 2015
13. Sulodexide for the Prevention of Recurrent Venous ThromboembolismCirculation · 2015
14. Aspirin for primary prevention in diabetes mellitus: from the calculation of cardiovascular risk and risk/benefit profile to personalised treatmentThrombosis and Haemostasis · 2015
15. MicroRNA-181b Regulates ALX/FPR2 Receptor Expression and Proresolution Signaling in Human MacrophagesJournal of Biological Chemistry · 2014
16. Oxidative Stress Drivers and Modulators in Obesity and Cardiovascular Disease: From Biomarkers to Therapeutic ApproachCurrent Medicinal Chemistry · 2014
17. Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapyHaematologica · 2014
18. Circulating Dickkopf‐1 in Diabetes Mellitus: Association With Platelet Activation and Effects of Improved Metabolic Control and Low‐Dose AspirinJournal of the American Heart Association · 2014
19. Circulating Myeloid‐Related Protein–8/14 is Related to Thromboxane‐Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low‐Dose Aspirin TreatmentJournal of the American Heart Association · 2014
20. Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A ‘state-of-the-art’ paperEuropean Heart Journal · 2014
21. Correlation between Migraine Severity and Cholesterol LevelsPain Practice · 2014
22. Estimated Glomerular Filtration Rate Is an Easy Predictor of Venous Thromboembolism in Cancer Patients Undergoing Platinum-Based ChemotherapyThe Oncologist · 2014
23. Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conoriiinfectionBMC Infectious Diseases · 2014
24. Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritisEuropean Journal of Dermatology · 2014
25. Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low‐HDL PhenotypeJournal of the American Heart Association · 2013
26. Effects of high-amount–high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axisThrombosis and Haemostasis · 2013
27. Obesity-Driven Inflammation and Colorectal CancerCurrent Medicinal Chemistry · 2012
28. A Complex Interaction between Rickettsia conorii and Dickkopf-1 – Potential Role in Immune Evasion Mechanisms in Endothelial CellsPLoS ONE · 2012
29. Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative StressThe Journal of Clinical Endocrinology & Metabolism · 2012
30. Platelet Function in Health and Disease: from Molecular Mechanisms, Redox Considerations to Novel Therapeutic OpportunitiesAntioxidants and Redox Signaling · 2012
31. Biomarkers of platelet activation in acute coronary syndromesThrombosis and Haemostasis · 2012
32. Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphismThrombosis and Haemostasis · 2012
33. Determinants of Increased Cardiovascular Disease in Obesity and Metabolic SyndromeCurrent Medicinal Chemistry · 2011
34. Platelet activation in obesity and metabolic syndromeObesity Reviews · 2011
35. Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge andin vivourinary thromboxane production in healthy male subjectsStress · 2011
36. Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: Beneficial effects of iloprostThrombosis and Haemostasis · 2010
37. Nutraceuticals in Diabetes and Metabolic SyndromeCardiovascular Therapeutics · 2010
38. Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory responseThe FASEB Journal · 2010
39. The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapyBlood · 2009
40. Soluble CD40 ligand and endothelial dysfunction in aspirin‐treated polycythaemia vera patientsBritish Journal of Haematology · 2009
41. Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical ImplicationsCurrent Medicinal Chemistry · 2009
42. CD40 Ligand and MCP-1 as Predictors of Cardiovascular Events in Diabetic Patients with StrokeJournal of Atherosclerosis and Thrombosis · 2009
43. Oxidative-induced membrane damage in diabetes lymphocytes: Effects on intracellular Ca2 +homeostasisFree Radical Research · 2009
44. Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirinThrombosis and Haemostasis · 2009
45. Thrombin as a common downstream target blocking both platelet and monocyte activationThrombosis and Haemostasis · 2009
46. Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patientsBlood · 2008
47. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuriaClinical Science · 2008
48. Platelet Activation and AtherothrombosisNew England Journal of Medicine · 2007
49. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjectsDiabetes/Metabolism Research and Reviews · 2007
50. Contribution of Platelet-Derived CD40 Ligand to Inflammation, Thrombosis and NeoangiogenesisCurrent Medicinal Chemistry · 2007